Advanced Enzyme Technologies Limited

NSE:ADVENZYMES.NS

477.45 (INR) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12012 Q42012 Q32012 Q2
Revenue 1,545.241,578.151,609.351,578.421,472.761,387.11,421.121,386.931,211.221,312.551,335.581,270.771,370.141,318.211,377.381,203.861,105.011,078.331,119.441,114.421,103.361,085.621,017.411,031.511,042.831,086.281,081.81985.78754.78860.19600.39908.03941.12804.57744.47704.68694.875543.265543.265561.27
Cost of Revenue 775.16772.73350.64370.04369.94335.69374.8335.81271.74413.55310.12246.28224.36369.2290.06185.67211.01242.74199.52242.16187.46260.43176.58205.98171.06185.14230.15248.92150.51197.27138.79132.66218.04151.62123.39194.93171.86545.12545.125220.53
Gross Profit 770.08805.421,258.711,208.381,102.821,051.411,046.321,051.12939.488991,025.461,024.491,145.78949.011,087.321,018.19894835.59919.92872.26915.9825.19840.83825.53871.77901.14851.66736.86604.27662.92461.6775.37723.08652.95621.08509.75523.01498.14498.14340.74
Gross Profit Ratio 0.4980.510.7820.7660.7490.7580.7360.7580.7760.6850.7680.8060.8360.720.7890.8460.8090.7750.8220.7830.830.760.8260.80.8360.830.7870.7470.8010.7710.7690.8540.7680.8120.8340.7230.7530.9170.9170.607
Reseach & Development Expenses 0216.68000216.59000193.73000155.13000218.65000219.01000134.1700097.1800083.3403.7453.74544.9744.971.83
General & Administrative Expenses 0282.31000246.36000262.64000220.85000204.12000231.91000229.77000152.35000142.410113.27113.2721.7521.7521.75
Selling & Marketing Expenses 062.1900063.9600055.9200026.3800047.6700038.8300026.9300017.4600016.9903.963.9613.3913.3918.94
SG&A 344.54344.5399.85378.44320.83310.32339.1377.35281.11318.56254.02256.86248.82247.23213.73214.16210.97251.79191.35204.83204.42270.74219.52195.89201.45256.7184.36161.42149.94169.81123.3131.04120.46159.4108.76117.23117.2343.9543.95103.145
Other Expenses 69.9394.99143.9660.9566.74110.7885.1538.719.9455.1412.068.999.33-1.1713.485.8252.343.2812.0515.3610.622.450.0420.163.785.642.554.913.216.046.75.954.235.653.183.410000
Operating Expenses 344.54344.5807.14782.53749.01694.43720.71742.43716.61605.02623.13617.64601.22458.43488.48501.06443.94388.74455.16464.29443.63341.24477.62456.81439.99464.27453.12372.67346.26368.19302.58321.09247.66280.45257.09253.34250.105305.39305.39111.38
Operating Income 425.54460.92595.53486.8353.81467.77410.76347.39222.87313.01402.33406.85544.56490.58598.84517.13450.06446.85464.76407.97472.27483.95363.21368.72431.78436.87398.54364.19258.01294.73159.02454.28475.42372.5363.99256.41280.21199.625199.625222.055
Operating Income Ratio 0.2750.2920.370.3080.240.3370.2890.250.1840.2380.3010.320.3970.3720.4350.430.4070.4140.4150.3660.4280.4460.3570.3570.4140.4020.3680.3690.3420.3430.2650.50.5050.4630.4890.3640.4030.3670.3670.396
Total Other Income Expenses Net 61.19-64.82-6.76-7.5360.25-46.74-6.23-6.0214.126.478.95.594.77-12.8710.231.9747.77-14.884.138.012.45-19.13.44-2.42-9.94-39.38-9.41-8.89-10.27-5.994.16-3.36-13.63-11.98-11.6-63.85-23.78-22.82-22.82-12.265
Income Before Tax 486.73396.1588.77479.27414.06421.03404.53341.37236.97339.48411.23412.44549.33477.71609.07519.1497.83431.97468.89415.98474.72464.85366.65366.3421.84397.49389.13355.3247.74288.74163.18450.92461.79360.52352.39192.56256.43176.805176.805209.79
Income Before Tax Ratio 0.3150.2510.3660.3040.2810.3040.2850.2460.1960.2590.3080.3250.4010.3620.4420.4310.4510.4010.4190.3730.430.4280.360.3550.4050.3660.360.360.3280.3360.2720.4970.4910.4480.4730.2730.3690.3250.3250.374
Income Tax Expense 136.9797.38163.75127.31120.2799.87125.4378.7661.1686.93125.68109.74150.71139.74166.04133.51149.78105.19123.3197.55135.04130.26113.18107.65109.52114.1124.04130.985.0789.3413.12158.31183.98133.21147.1845.2275.8564.7564.7567.48
Net Income 341.52283.11417.74344.08288.1321.24294.36262.08178.73244.32274.84296.98380.41316.76430.88371.86342.49313.32336.05309.53334.03322.14244.46247.34296.65272.43251.91218.42157.78197.97143.81289.13271.73233.98199.14144.72175.795109.69109.69139.385
Net Income Ratio 0.2210.1790.260.2180.1960.2320.2070.1890.1480.1860.2060.2340.2780.240.3130.3090.310.2910.30.2780.3030.2970.240.240.2840.2510.2330.2220.2090.230.240.3180.2890.2910.2670.2050.2530.2020.2020.248
EPS 3.052.533.743.082.582.872.632.341.62.192.462.653.412.843.863.333.072.813.012.772.992.882.192.212.662.442.261.961.461.951.242.592.52.151.831.331.621.011.011.33
EPS Diluted 3.052.533.743.082.582.872.632.341.62.192.452.653.42.843.853.333.062.813.012.772.992.882.192.212.662.432.251.961.461.951.242.592.52.151.831.331.621.011.011.33
EBITDA 511.67553.68681.57574.07506.89552.26502.05435.48329.23437.08502.6501.85636.88567.92677.33590.95569.62513.68540.75488.04545.47523.31417.27441.39487.39489.63454.09414.41298.77332.76196.9487.89510.8400.81389.26279.61301.435222.58222.58236.25
EBITDA Ratio 0.3310.3510.4240.3640.3440.3980.3530.3140.2720.3330.3760.3950.4650.4310.4920.4910.5150.4760.4830.4380.4940.4820.410.4280.4670.4510.420.420.3960.3870.3280.5370.5430.4980.5230.3970.4340.410.410.421